Bioactivity of miltefosine against aquatic stages of <it>Schistosoma mansoni, Schistosoma haematobium </it>and their snail hosts, supported by scanning electron microscopy
<p>Abstract</p> <p>Background</p> <p>Miltefosine, which is the first oral drug licensed for the treatment of leishmaniasis, was recently reported to be a promising lead compound for the synthesis of novel antischistosomal derivatives with potent activity <it>in vi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-05-01
|
| Series: | Parasites & Vectors |
| Online Access: | http://www.parasitesandvectors.com/content/4/1/73 |